SCHEMBL29066201

SCHEMBL29066201

Cc1cc(Oc2c(Cl)cc(-n3nc(C(=O)O)c(=O)[nH]c3=O)cc2Cl)cn(C(C)C)c1=O

nearest known ligand 0.58

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
THRA P10827 12/20 0.58
THRB P10828 14/20 0.49
CYP2C9 P11712 2/20 0.41
CYP2C8 P10632 1/20 0.41
UGT1A1 P22309 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
SLCO1B1 Q9Y6L6 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.37
STAT1 P42224 1/20 0.36
ATM Q13315 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29066195 0.90 THRA (0.57) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL23168580 0.87 THRA (0.60) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL24407940 0.86 THRB (0.56) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL29066193 0.85 THRB (0.45) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL29066210 0.84 THRA (0.61) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL29066203 0.82 THRA (0.67) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL29632804 0.81 THRB (0.63) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL29526823 0.79 THRB (0.47) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL29527126 0.79 THRA (0.55) THRATHRBCYP2C9CYP2C8UGT1A1
SCHEMBL11463732 0.79 THRA (0.54) THRATHRBCYP2C9UGT1A1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240730-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS Aligos Therapeutics, Inc. (US) 2023-09-13 EP disclosed
CN-116710443-A 2-pyridones as thyroid hormone receptor modulators 阿利戈斯治疗公司 2023-09-05 CN disclosed
WO-2022099044-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 WO disclosed